Complement Deficiencies
Gene: CFHR3
PMID: 32424742 - Czech cohort of chlidren with aHUS, many had a whole gene deletion of CFHR1/CFHR3. Patients were either hom, or het with a 2nd mutation in another gene.
Reports of SNVs are minimal in pubmed and OMIM/Decipher/ClinVarCreated: 11 Feb 2021, 1:36 a.m. | Last Modified: 11 Feb 2021, 1:36 a.m.
Panel Version: 0.6314
Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Phenotypes
{Hemolytic uremic syndrome, atypical, susceptibility to} MIM#235400; {Macular degeneration, age-related, reduced risk of} MIM#603075
Publications
Association is with aHUS, gene is included in aHUS panel.Created: 10 Apr 2020, 3:27 a.m. | Last Modified: 10 Apr 2020, 3:27 a.m.
Panel Version: 0.17
Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Phenotypes
{Hemolytic uremic syndrome, atypical, susceptibility to}, MIM# 235400
Gene: cfhr3 has been classified as Red List (Low Evidence).
Phenotypes for gene: CFHR3 were changed from to {Hemolytic uremic syndrome, atypical, susceptibility to}, MIM# 235400
Mode of inheritance for gene: CFHR3 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Gene: cfhr3 has been classified as Red List (Low Evidence).
gene: CFHR3 was added gene: CFHR3 was added to Complement deficiencies_MGHA_AGHA_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: CFHR3 was set to Unknown